In stock
Lintra 5mg FC Tablets
In stock
Only 1 left
SKU
10331006554
Lintra (Linagliptin 5mg FC) Tablets are prescribed for adults with Type 2 Diabetes Mellitus to help manage blood sugar levels. This once-daily medication works to improve insulin release and reduce sugar production by the liver. Use as directed by a healthcare professional.
Product Overview
Lintra (Linagliptin 5mg FC) Tablets are an advanced medication specifically formulated for adults diagnosed with Type 2 Diabetes Mellitus.
This once-daily oral tablet is designed to help effectively manage blood sugar levels as part of a comprehensive diabetes management plan.
As a dipeptidyl peptidase-4 (DPP-4) inhibitor, Linagliptin works by enhancing the body's natural ability to lower high blood glucose.
Key Benefits
- Helps to significantly reduce elevated blood sugar levels, contributing to better glycemic control.
- Stimulates the release of insulin from the pancreas in a glucose-dependent manner, particularly after meals.
- Decreases the production of glucose by the liver, further aiding in blood sugar management.
- Convenient once-daily dosing regimen supports patient adherence.
- Can be used alone or in combination with other anti-diabetic medications as prescribed by a healthcare professional.
How to Use
- Take one Lintra 5mg tablet orally once daily.
- The tablet can be taken with or without food, at any time of day.
- Swallow the tablet whole with a glass of water; do not crush or chew.
- Always use Lintra exactly as your doctor or pharmacist has told you.
- It is crucial to continue following your diet and exercise plan while taking this medication.
- Regularly monitor your blood glucose levels as advised by your healthcare provider.
Caution & Warnings
- Consult your doctor if you experience severe and persistent abdominal pain, which could be a symptom of pancreatitis.
- Inform your doctor if you have kidney problems, as dose adjustments may be necessary for some diabetes medications (though Linagliptin is generally well-tolerated in renal impairment).
- Be aware of the risk of hypoglycemia (low blood sugar), especially when used in combination with sulfonylureas or insulin.
- Discontinue use and seek immediate medical attention if you develop signs of a serious allergic reaction, such as rash, hives, swelling of the face, lips, tongue, or throat, and difficulty breathing or swallowing.
- Not indicated for patients with Type 1 Diabetes Mellitus or for the treatment of diabetic ketoacidosis.
- Keep out of the sight and reach of children.
- Do not use after the expiry date stated on the carton.
Ingredients
Active Ingredient:
Linagliptin 5mg
Excipients:
Typically includes microcrystalline cellulose, pregelatinized starch, maize starch, copovidone, magnesium stearate, and a film coating (e.g., Opadry). Specific excipients may vary; refer to the package leaflet for precise details.
Product Details
Brand: Lintra
Manufacturer: Jazeera Pharmaceutical Industries (JPI)
Form: Film-Coated Tablets
Strength: 5mg
Package Size: 30 Tablets
| Gtin | 06285128021562 |
|---|---|
| Recommended Sale Price | 94.8 |
| Is Wasfaty Product | No |
| Brand | Lintra |
| Principle | Linagliptin |
| Ingredient Name | LINAGLIPTIN |
| SFDA Reg. No | 0901244693 |
| IBC | 06285128021562 |
| Drug Type | Prescription |
| Scientific Name | Linagliptin |
| Strength | 5 |
| Strength Unit | mg |
| Form | Tablets |
| Admin Route | Oral |
| Size | 30 |
| Size Unit | Tablets |
| Package Types | Blister pack |
| Package Size | 30 Tablets |
| shelfLife | 24 months |
| Storage conditions | Store below 30C. Protect from moisture. |
| Refrigerator Storage | false |
| Distribute area | Saudi Arabia |









